Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
NCT00476931
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
91
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Diabetic Polyneuropathy
Interventions
BIOLOGICAL:
SB-509
OTHER:
Placebo
Sponsor
Sangamo Therapeutics